Data / Research funding / Brain Disorders
Brain Disorders: 26,960 NIH awards ($37.6B) to 1,664 organizations
26,960 NIH awards ($37.6B) in the NIH spending category Brain Disorders, to 1,664 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 26,960 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Health and Retirement Study: Yrs 35-40 | NIH | National Institute on Aging | 2021 to 2025 | $142,220,153 | September 25, 1990 | December 31, 2029 | WEIR, DAVID R. | reporter.nih.gov |
| Alzheimer's Clinical Trials Consortium (ACTC) | NIH | National Institute on Aging | 2021 to 2025 | $119,771,576 | December 2, 2017 | August 31, 2028 | AISEN, PAUL S. | reporter.nih.gov |
| Alzheimer's Disease Neuroimaging Initiative (ADNI4) | NIH | National Institute on Aging | 2022 to 2025 | $95,332,786 | September 30, 2004 | July 31, 2028 | WEINER, MICHAEL W | reporter.nih.gov |
| Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS) | NIH | National Institute on Aging | 2021 to 2025 | $82,684,947 | September 30, 2020 | August 31, 2026 | HANDEN, BENJAMIN L | reporter.nih.gov |
| DIAN-TU Primary Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $79,373,454 | September 15, 2018 | May 31, 2026 | MCDADE, ERIC MARTIN | reporter.nih.gov |
| NIA AD/ADRD Health Care Systems Research Collaboratory | NIH | National Institute on Aging | 2021 to 2025 | $69,169,841 | September 1, 2019 | August 31, 2030 | MOR, VINCENT | reporter.nih.gov |
| Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project | NIH | National Institute on Aging | 2022 to 2025 | $66,521,567 | September 1, 2022 | August 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| NIDA Clinical Trials Network: New York Node (CTN-0139, CTN-0155, CTN-Biostats) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $66,452,521 | March 1, 2025 | February 29, 2032 | MCNEELY, JENNIFER | reporter.nih.gov |
| National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | NIH | National Institute on Aging | 2021 to 2025 | $65,403,220 | July 15, 2002 | May 31, 2027 | FOROUD, TATIANA M. | reporter.nih.gov |
| The National Health and Aging Trends Study and National Study of Caregiving | NIH | National Institute on Aging | 2021 to 2025 | $65,386,641 | September 30, 2008 | March 31, 2029 | SCHRACK, JENNIFER ANN | reporter.nih.gov |
| ProNET: Psychosis-Risk Outcomes Network | NIH | National Institute of Mental Health | 2021 to 2025 | $61,984,741 | September 8, 2020 | May 31, 2026 | WOODS, SCOTT W | reporter.nih.gov |
| The Alzheimer's Disease Tau Platform Clinical Trial | NIH | National Institute on Aging | 2023 to 2024 | $60,700,604 | September 21, 2023 | August 31, 2028 | BOXER, ADAM L. | reporter.nih.gov |
| ADRC Consortium for Clarity in ADRD Research Through Imaging | NIH | National Institute on Aging | 2023 to 2024 | $60,357,563 | September 15, 2023 | August 31, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| The Long Life Family Study | NIH | National Institute on Aging | 2021 to 2025 | $60,108,132 | August 15, 2019 | June 30, 2030 | PROVINCE, MICHAEL A. | reporter.nih.gov |
| CTN New England Consortium Node | NIH | National Institute on Drug Abuse | 2021 to 2025 | $58,365,118 | March 1, 2025 | February 29, 2032 | D'ONOFRIO, GAIL | reporter.nih.gov |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) | NIH | National Institute on Aging | 2021 to 2025 | $56,766,232 | September 15, 2019 | August 31, 2030 | BOEVE, BRADLEY F | reporter.nih.gov |
| NRG Oncology NCORP Research Base-BIQSFP | NIH | National Cancer Institute | 2021 to 2025 | $54,340,726 | July 11, 2025 | July 31, 2026 | BRUNER, DEBORAH WATKINS | reporter.nih.gov |
| Access for All in ALS (ALL ALS) West Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $51,203,440 | September 25, 2023 | June 30, 2027 | BOWSER, ROBERT P | reporter.nih.gov |
| DIAN-TU: Tau Next Generation Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $49,839,335 | September 15, 2020 | May 31, 2027 | BATEMAN, RANDALL J | reporter.nih.gov |
| Access for All in ALS (ALL ALS) East Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $49,098,369 | September 25, 2023 | June 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| A multimodal brain cell atlas and community resource of Alzheimer's disease and comorbid dementias. | NIH | National Institute on Aging | 2021 to 2025 | $48,445,852 | March 1, 2020 | August 31, 2030 | LEIN, ED | reporter.nih.gov |
| National Alzheimer's Coordinating Center | NIH | National Institute on Aging | 2021 to 2025 | $45,845,722 | June 15, 2021 | May 31, 2027 | STEPHENS, KARI A | reporter.nih.gov |
| IU/JAX/PITT MODEL-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $45,129,948 | September 30, 2016 | August 31, 2027 | LAMB, BRUCE T | reporter.nih.gov |
| NIDA Clinical Trials Network: Big South/West Node (CTN-0132 and CTN-0139) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $43,417,361 | March 1, 2025 | February 28, 2032 | TRIVEDI, MADHUKAR H. | reporter.nih.gov |
| Longitudinal multicenter head-to-head harmonization of tau PET tracers | NIH | National Institute on Aging | 2021 to 2025 | $41,111,092 | September 1, 2021 | May 31, 2027 | PASCOAL, THARICK | reporter.nih.gov |
| UC Irvine MODEL-AD | NIH | National Institute on Aging | 2021 to 2025 | $40,119,354 | September 15, 2017 | August 31, 2027 | LAFERLA, FRANK M | reporter.nih.gov |
| Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months | NIH | National Institute on Aging | 2021 to 2025 | $39,702,286 | June 1, 2020 | May 31, 2027 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Wisconsin longitudinal study: Initial lifetime's impact on Alzheimer's disease and related disorders (WLS-ILIAD) | NIH | National Institute on Aging | 2021 to 2025 | $39,317,019 | September 15, 2018 | February 29, 2028 | ASTHANA, SANJAY | reporter.nih.gov |
| Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders | NIH | National Institute of Mental Health | 2021 to 2024 | $39,202,732 | July 1, 2003 | February 28, 2026 | KNOWLES, JAMES A | reporter.nih.gov |
| Study of Muscle, Mobility and Aging: SOMMA2 | NIH | National Institute on Aging | 2021 to 2025 | $38,028,895 | June 15, 2018 | June 30, 2029 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium | NIH | National Institute on Aging | 2021 to 2025 | $37,497,984 | September 30, 2021 | August 31, 2026 | HOHMAN, TIMOTHY J | reporter.nih.gov |
| Cognitive training to reduce incidence of cognitive impairment in older adults | NIH | National Institute on Aging | 2021 to 2024 | $37,326,564 | February 1, 2021 | January 31, 2027 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| Health and Aging Brain among Latino Elders (HABLE-AT(N)) Study | NIH | National Institute on Aging | 2021 to 2025 | $36,277,689 | August 1, 2020 | April 30, 2027 | O'BRYANT, SID E | reporter.nih.gov |
| Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study | NIH | National Institute on Aging | 2021 to 2024 | $36,190,244 | August 15, 2020 | May 31, 2025 | ABUSHAKRA, SUSAN | reporter.nih.gov |
| Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term) | NIH | National Institute on Drug Abuse | 2021 to 2022 | $36,092,167 | April 17, 2019 | March 31, 2025 | WALSH, SHARON L. | reporter.nih.gov |
| Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) | NIH | National Institute on Aging | 2022 to 2025 | $35,910,792 | July 1, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD) | NIH | National Institute on Aging | 2021 to 2025 | $35,388,433 | March 1, 2021 | May 31, 2026 | KIND, AMY J. | reporter.nih.gov |
| The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $35,158,235 | February 15, 2021 | January 31, 2027 | LAH, JAMES J | reporter.nih.gov |
| Combination anti-amyloid therapy for preclinical Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2024 | $34,903,050 | September 30, 2018 | May 31, 2025 | AISEN, PAUL S. | reporter.nih.gov |
| A Next Generation Data Infrastructure to Understand Disparities across the Life Course | NIH | National Institute on Aging | 2023 to 2025 | $34,372,705 | August 15, 2023 | July 31, 2028 | KAPTEYN, ARIE | reporter.nih.gov |
| FY25 AWARD. NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2025 - SEPTEMBER 16, 2026. N01DA-21-5588. TASK ORDER 75N95025F00001 (TO5). | NIH | National Institute on Drug Abuse | 2021 to 2025 | $34,168,377 | September 17, 2025 | September 16, 2026 | reporter.nih.gov | |
| CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27. | NIH | National Institute on Drug Abuse | 2021 to 2025 | $33,434,913 | August 28, 2023 | August 27, 2026 | JELSTROM, EVE | reporter.nih.gov |
| Pediatric Eye Disease Investigator Group Coordinating Center | NIH | National Eye Institute | 2021 to 2025 | $33,066,572 | May 1, 1997 | December 31, 2028 | KRAKER, RAYMOND | reporter.nih.gov |
| Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $33,014,143 | September 25, 2023 | April 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2024 to 2025 | $32,776,590 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| Early Onset AD Consortium - the LEAD Study (LEADS) | NIH | National Institute on Aging | 2021 to 2023 | $31,594,379 | September 30, 2018 | May 31, 2025 | APOSTOLOVA, LIANA G | reporter.nih.gov |
| ProCAN: Psychosis Risk Outcomes Compound Assessment Network | NIH | National Institute of Mental Health | 2024 to 2025 | $31,583,752 | June 14, 2024 | May 31, 2029 | WOODS, SCOTT W | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $31,474,131 | September 26, 2025 | September 25, 2026 | reporter.nih.gov | |
| IUSM TREAT-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $31,208,587 | September 30, 2019 | November 30, 2029 | PALKOWITZ, ALAN D. | reporter.nih.gov |
| Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $30,295,384 | July 15, 2022 | June 30, 2028 | GIBSON, GARY E | reporter.nih.gov |
| The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) | NIH | National Institute on Aging | 2024 to 2025 | $30,281,212 | August 15, 2024 | July 31, 2029 | BOXER, ADAM L. | reporter.nih.gov |
| MassHEAL - Reducing overdose deaths by 40% (2019-2023) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $29,970,213 | September 15, 2023 | March 31, 2024 | SAMET, JEFFREY H. | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 to 2023 | $29,498,064 | May 15, 2021 | April 30, 2025 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $28,395,368 | September 1, 2022 | August 31, 2027 | SILVA, AFONSO C | reporter.nih.gov |
| An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $27,895,551 | September 25, 2023 | August 31, 2027 | PAGANONI, SABRINA | reporter.nih.gov |
| Bridge Funding for Dominantly Inherited Alzheimer Network | NIH | National Institute on Aging | 2021 to 2025 | $27,724,157 | September 15, 2008 | June 30, 2026 | BATEMAN, RANDALL J | reporter.nih.gov |
| The INCLUDE Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $27,560,616 | September 26, 2020 | August 31, 2030 | RESNICK, ADAM CAIN | reporter.nih.gov |
| RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 2 - COMMERCIALIZATION CENTER - HEAL | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $27,543,152 | June 2, 2025 | June 1, 2026 | reporter.nih.gov | |
| Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $26,536,563 | September 1, 2021 | May 31, 2028 | HOH, BRIAN LIM | reporter.nih.gov |
| A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $26,526,303 | September 20, 2023 | July 31, 2027 | JIANG, YONG-HUI | reporter.nih.gov |
| The Florida Node Alliance of the National Drug Abuse Clinical Trials Network (CTN-121) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $26,301,696 | March 1, 2025 | February 29, 2028 | SZAPOCZNIK, JOSE | reporter.nih.gov |
| API A4 Alzheimer's Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $26,251,396 | September 1, 2018 | November 30, 2025 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25). | NIH | National Institute on Drug Abuse | 2022 to 2025 | $25,789,598 | March 1, 2025 | February 28, 2026 | reporter.nih.gov | |
| BPN-MCSP-HIT TO LEAD CHEMISTRY- MARTIN (NUVONURO) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $25,707,343 | December 9, 2024 | June 8, 2026 | MICHELS, PETER C | reporter.nih.gov |
| ASPirin in Reducing Events in the Elderly - eXTension | NIH | National Institute on Aging | 2021 to 2023 | $24,851,437 | July 15, 2019 | April 30, 2026 | MURRAY, ANNE M | reporter.nih.gov |
| US POINTER Neuroimaging Ancillary Study | NIH | National Institute on Aging | 2021 to 2025 | $24,762,483 | August 1, 2019 | March 31, 2027 | LANDAU, SUSAN M | reporter.nih.gov |
| Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia | NIH | National Institute on Aging | 2021 to 2024 | $24,586,693 | September 15, 2020 | May 31, 2026 | FARRER, LINDSAY A. | reporter.nih.gov |
| Center without Walls for Imaging Proteinopathies with PET | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $24,457,384 | September 24, 2019 | July 31, 2029 | MACH, ROBERT H | reporter.nih.gov |
| Asian Cohort for Alzheimer's Disease (ACAD) | NIH | National Institute on Aging | 2023 to 2025 | $24,263,451 | July 1, 2023 | June 30, 2028 | WANG, LI-SAN | reporter.nih.gov |
| Chicago Chronic Conditions Engagement Network | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,257,718 | September 24, 2021 | June 30, 2027 | HUANG, ELBERT S. | reporter.nih.gov |
| Metformin in Alzheimer's dementia Prevention (MAP) | NIH | National Institute on Aging | 2021 to 2025 | $24,224,790 | August 15, 2019 | April 30, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | NIH | National Institute of Mental Health | 2021 to 2025 | $24,090,655 | September 8, 2020 | May 31, 2026 | NELSON, CHRISTOPHER BARNABY | reporter.nih.gov |
| Integrating Information about Aging Surveys: Novel Integration of Contextual Data to Study Late-Life Cognition and Alzheimer’s Disease and Related Dementia and Dementia Care | NIH | National Institute on Aging | 2021 to 2025 | $23,672,206 | May 1, 2007 | March 31, 2027 | LEE, JINKOOK | reporter.nih.gov |
| Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study | NIH | National Institute on Aging | 2021 to 2024 | $23,438,396 | May 15, 2019 | December 31, 2025 | SPERLING, REISA A. | reporter.nih.gov |
| Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $23,431,388 | August 15, 2021 | July 31, 2027 | MUCKE, LENNART | reporter.nih.gov |
| Psychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT): Data Processing, Analysis, and Coordination Center | NIH | National Institute of Mental Health | 2021 to 2024 | $23,322,808 | September 9, 2020 | May 31, 2026 | SHENTON, MARTHA E. | reporter.nih.gov |
| Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | NIH | National Institute on Aging | 2023 to 2025 | $23,106,653 | August 15, 2023 | July 31, 2028 | DE ERAUSQUIN, GABRIEL ALEJANDRO | reporter.nih.gov |
| Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO) | NIH | National Institute on Aging | 2021 to 2025 | $23,099,141 | September 30, 2021 | August 31, 2027 | PERLS, THOMAS T | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $22,785,879 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| Mount Sinai ECHO site for Perinatal Environment and Development Studies | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $22,671,567 | September 21, 2016 | May 31, 2030 | WRIGHT, ROSALIND J | reporter.nih.gov |
| NorthStar Node of the NIDA Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $22,374,119 | September 1, 2015 | February 29, 2032 | BART, GAVIN | reporter.nih.gov |
| THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE | NIH | National Institute on Aging | 2021 to 2025 | $21,982,300 | April 1, 2012 | April 30, 2027 | WANG, LI-SAN | reporter.nih.gov |
| REVEAL - Research Evaluating Vagal Excitation and Anatomical Linkages. | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $21,646,919 | September 23, 2022 | August 31, 2025 | OSBORN, JOHN W | reporter.nih.gov |
| Wisconsin Registry for Alzheimer's Prevention | NIH | National Institute on Aging | 2023 to 2025 | $21,491,270 | June 1, 2023 | February 29, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| BRAIN CONNECTS: A Center for High-throughput Integrative Mouse Connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $21,489,807 | September 8, 2023 | August 31, 2028 | LICHTMAN, JEFF W | reporter.nih.gov |
| APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $21,355,638 | September 30, 2020 | March 31, 2027 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $21,254,211 | September 6, 2024 | September 5, 2026 | HANANIA, TALEEN | reporter.nih.gov |
| Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease | NIH | National Institute on Aging | 2021 to 2025 | $21,188,740 | September 30, 2021 | August 31, 2027 | PAULSEN, JANE S | reporter.nih.gov |
| Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging | NIH | National Institute on Aging | 2021 to 2025 | $21,174,898 | September 30, 2021 | May 31, 2027 | DEMIRIS, GEORGE | reporter.nih.gov |
| A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2023 to 2025 | $21,072,036 | February 1, 2023 | January 31, 2026 | ALAM, JOHN | reporter.nih.gov |
| Delaware Clinical and Translational Research ACCEL Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,011,968 | September 25, 2013 | June 30, 2028 | HICKS, GREGORY E | reporter.nih.gov |
| The Origins of Alzheimer Disease in African Americans | NIH | National Institute on Aging | 2022 to 2025 | $20,889,453 | September 15, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $20,858,598 | March 23, 2022 | December 31, 2025 | WILCOX, KAREN | reporter.nih.gov |
| Alzheimer's Gut Microbiome Project | NIH | National Institute on Aging | 2021 to 2023 | $20,743,566 | September 15, 2019 | August 31, 2025 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Frontotemporal Dementia: Genes, Images, and Emotions | NIH | National Institute on Aging | 2021 to 2025 | $20,694,825 | September 1, 2002 | April 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in Cohort of Oldest-Old | NIH | National Institute on Aging | 2022 to 2025 | $20,680,832 | September 15, 2017 | June 30, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative | NIH | National Institute on Aging | 2022 to 2024 | $20,575,729 | September 1, 2022 | August 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $20,420,182 | September 30, 2013 | August 31, 2028 | KRISHNAN-SARIN, SUCHITRA | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| IDeA Networks of Biomedical Research Excellence in Kentucky | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,119,568 | September 30, 2001 | April 30, 2029 | ROUCHKA, ERIC C | reporter.nih.gov |
| Einstein Aging Study | NIH | National Institute on Aging | 2021 to 2024 | $20,102,748 | September 29, 1982 | March 31, 2028 | DERBY, CAROL A. | reporter.nih.gov |
| South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,943,827 | September 30, 2001 | August 31, 2026 | GOLDSMITH, EDIE C | reporter.nih.gov |
| Massachusetts Alzheimer's Disease Research Center (MADRC) | NIH | National Institute on Aging | 2021 to 2025 | $19,915,545 | May 15, 2019 | March 31, 2029 | GOMEZ-ISLA, TERESA | reporter.nih.gov |
| National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS) | NIH | National Institute on Aging | 2021 to 2025 | $19,881,397 | August 1, 2017 | April 30, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| Analyses to Reveal Trajectories and Early Markers of Imminent Shifts in Suicidal States | NIH | National Institute of Mental Health | 2025 | $19,515,757 | August 18, 2025 | August 17, 2029 | TURNER, JESS | reporter.nih.gov |
| Oklahoma IDeA Network of Biomedical Research Excellence | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,194,069 | September 6, 2001 | August 31, 2030 | LANG, MARK L | reporter.nih.gov |
| UCSD Shiley-Marcos Alzheimer's Disease Research Center P30 | NIH | National Institute on Aging | 2021 to 2025 | $18,959,959 | May 1, 2019 | March 31, 2029 | BREWER, JAMES B | reporter.nih.gov |
| JCOIN Phase II Coordination and Translation Center | NIH | National Institute on Drug Abuse | 2021 to 2025 | $18,785,790 | September 30, 2019 | May 31, 2029 | TAXMAN, FAYE S | reporter.nih.gov |
| Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI) | NIH | National Institute on Aging | 2021 to 2025 | $18,706,904 | September 15, 2013 | May 31, 2028 | BERKMAN, LISA F | reporter.nih.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $18,588,752 | March 1, 2025 | February 29, 2032 | WINHUSEN, T JOHN | reporter.nih.gov |
| Mayo Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $18,486,241 | July 1, 2019 | April 30, 2029 | BOEVE, BRADLEY F | reporter.nih.gov |
| Dynamic Cognitive Phenotypes for Prediction of Mental Health Outcomes in Serious Mental Illness | NIH | National Institute of Mental Health | 2025 | $18,270,924 | September 10, 2025 | September 9, 2029 | GERMINE, LAURA THI | reporter.nih.gov |
| State-dependent Decision-making in Brainwide Neural Circuits | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $18,155,129 | August 15, 2021 | July 31, 2027 | PANINSKI, LIAM M | reporter.nih.gov |
| An Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $18,136,504 | September 28, 2022 | August 31, 2025 | PAGANONI, SABRINA | reporter.nih.gov |
| Lifecourse health, cerebral pathology and differences in dementia risk (KHANDLE Study) | NIH | National Institute on Aging | 2021 to 2025 | $18,022,067 | June 1, 2016 | February 28, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $17,997,906 | May 15, 2022 | January 31, 2028 | GONZALEZ, HECTOR M | reporter.nih.gov |
| Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $17,995,278 | September 1, 2022 | November 30, 2026 | BENSOUSSAN, YAEL EMILIE | reporter.nih.gov |
| Mount Sinai Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,735,870 | May 1, 2020 | March 31, 2030 | SANO, MARY | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2021 to 2024 | $17,711,217 | September 1, 2019 | August 31, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Additional Sequencing for the Alzheimer's Disease Sequencing Project (ADSP) | NIH | National Institute on Aging | 2021 to 2024 | $17,661,924 | July 1, 2020 | June 30, 2026 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Northeast Node of the National Drug Abuse Treatment Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $17,509,561 | March 1, 2025 | February 28, 2030 | MARSCH, LISA A. | reporter.nih.gov |
| Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,255,961 | June 15, 2020 | April 30, 2030 | SMALL, SCOTT A | reporter.nih.gov |
| Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal) | NIH | National Institute on Aging | 2021 to 2025 | $17,112,209 | August 15, 2018 | May 31, 2029 | HUGHES, TIMOTHY M. | reporter.nih.gov |
| Offspring Study of Mechanisms for Racial Disparities in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $17,095,138 | September 1, 2016 | May 31, 2027 | MANLY, JENNIFER JAIE | reporter.nih.gov |
| NORTHWESTERN Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,093,229 | August 15, 2021 | June 30, 2026 | VASSAR, ROBERT J | reporter.nih.gov |
| Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | NIH | National Institute on Aging | 2022 to 2025 | $17,073,728 | September 1, 2022 | June 30, 2027 | NORRIS, CHRISTOPHER MARK | reporter.nih.gov |
| Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) | NIH | National Institute on Aging | 2023 to 2025 | $17,039,516 | August 15, 2023 | April 30, 2028 | HARRIS, KATHLEEN MULLAN | reporter.nih.gov |
| Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort | NIH | National Institute on Aging | 2021 to 2025 | $16,952,609 | July 1, 2009 | May 31, 2027 | ALBERT, MARILYN S. | reporter.nih.gov |
| Goizueta Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $16,684,611 | July 15, 2020 | April 30, 2030 | LEVEY, ALLAN I | reporter.nih.gov |
| 1/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $16,489,352 | September 15, 2021 | August 31, 2028 | MOLER, FRANK W | reporter.nih.gov |
| Diabetes and brain amyloid in middle aged Hispanics | NIH | National Institute on Aging | 2021 to 2025 | $16,383,484 | September 1, 2015 | May 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Cognition & Hippocampal/Cortical Systems in Aging | NIH | National Institute on Aging | 2021 to 2025 | $16,383,227 | September 1, 1997 | March 31, 2027 | KNIERIM, JAMES J | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Round 5 | NIH | National Institute on Aging | 2021 to 2025 | $16,330,170 | September 15, 2014 | April 30, 2029 | WAITE, LINDA J | reporter.nih.gov |
| University of Kansas Alzheimer's Disease Research Center (KU ADRC) | NIH | National Institute on Aging | 2021 to 2025 | $16,309,323 | August 15, 2021 | June 30, 2026 | SWERDLOW, RUSSELL H. | reporter.nih.gov |
| Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic Transitions | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $16,244,011 | September 24, 2001 | August 31, 2026 | JUDD, SUZANNE E | reporter.nih.gov |
| CWRU Center for Excellence on the Impact of Substance Use on HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $16,213,687 | September 15, 2021 | May 31, 2027 | LEVINE, ALAN DAVID | reporter.nih.gov |
| National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Cognition and Early Risk Factors for Dementia Project | NIH | National Institute on Aging | 2021 to 2025 | $16,156,406 | January 15, 2021 | December 31, 2026 | HUMMER, ROBERT A | reporter.nih.gov |
| The Alzheimer's Disease Research Center at the University of California, Irvine | NIH | National Institute on Aging | 2021 to 2025 | $16,032,156 | June 15, 2020 | March 31, 2030 | LAFERLA, FRANK M | reporter.nih.gov |
| Alzheimer's Disease Genetics Consortium | NIH | National Institute on Aging | 2021 to 2024 | $15,948,152 | April 1, 2009 | March 31, 2026 | SCHELLENBERG, GERARD DAVID | reporter.nih.gov |
| Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $15,805,224 | July 1, 2018 | November 30, 2025 | BARSAN, WILLIAM G | reporter.nih.gov |
| Arizona Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $15,728,435 | September 5, 2021 | June 30, 2027 | LANGBAUM, JESSICA BROOKE | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2021 to 2022 | $15,706,591 | May 15, 2019 | February 29, 2024 | WARREN, JOHN ROBERT | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,682,941 | July 7, 2010 | March 31, 2024 | CORESH, JOSEF | reporter.nih.gov |
| Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias | NIH | National Institute on Aging | 2021 to 2025 | $15,514,157 | September 30, 2021 | May 31, 2027 | ELLERBY, LISA M | reporter.nih.gov |
| Center for Pacific Innovations, Knowledge, and Opportunities (PIKO) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $15,507,862 | September 1, 2021 | July 31, 2027 | KAHOLOKULA, JOSEPH KEAWE'AIMOKU | reporter.nih.gov |
| Therapeutic Editing to Lower PrP in Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $15,507,691 | May 17, 2023 | April 30, 2026 | VALLABH, SONIA MINIKEL | reporter.nih.gov |
| The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4) | NIH | National Institute on Aging | 2021 to 2024 | $15,274,483 | September 1, 2015 | March 31, 2026 | PANIZZON, MATTHEW S | reporter.nih.gov |
| A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $15,144,108 | September 15, 2021 | August 31, 2027 | CLARDY, STACEY LYNN | reporter.nih.gov |
| Leveraging Artificial Intelligence to Predict Mental Health Risk among Youth Presenting to Rural Primary Care Clinics | NIH | National Institute of Mental Health | 2025 | $15,039,330 | September 10, 2025 | September 9, 2029 | POSNER, JONATHAN E | reporter.nih.gov |
| Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,990,990 | August 1, 2008 | June 30, 2030 | DIAMOND, BETTY | reporter.nih.gov |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,978,926 | August 25, 2022 | July 31, 2029 | PASSMAN, ROD S | reporter.nih.gov |
| NIH NATIONAL BRAIN AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,799,056 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Johns Hopkins University Trial Innovation Center | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $14,762,337 | July 5, 2023 | April 30, 2028 | HANLEY, DANIEL F | reporter.nih.gov |
| English Longitudinal Study of Ageing - Renewal 2024 | NIH | National Institute on Aging | 2021 to 2025 | $14,720,227 | September 30, 2000 | May 31, 2029 | STEPTOE, ANDREW | reporter.nih.gov |
| Alzheimer's Disease Research Centers | NIH | National Institute on Aging | 2021 to 2025 | $14,719,450 | September 1, 2020 | March 31, 2030 | CHUI, HELENA CHANG | reporter.nih.gov |
| Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies | NIH | National Institute on Aging | 2022 to 2025 | $14,689,794 | September 15, 2019 | December 31, 2026 | PERLS, THOMAS T | reporter.nih.gov |
| Causes and Consequences of Healthcare Inefficiency in Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $14,684,279 | August 1, 2001 | July 31, 2028 | BARNATO, AMBER E | reporter.nih.gov |
| Alzheimer's Disease Research Center - Administrative Supplement 2025 | NIH | National Institute on Aging | 2021 to 2025 | $14,671,380 | May 1, 2020 | April 30, 2026 | WISNIEWSKI, THOMAS M | reporter.nih.gov |
| Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $14,626,193 | May 1, 2017 | April 30, 2024 | AISEN, PAUL S. | reporter.nih.gov |
| Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration | NIH | National Institute on Drug Abuse | 2022 to 2025 | $14,516,969 | June 1, 2022 | March 31, 2027 | ZENG, HONGKUI | reporter.nih.gov |
| Advancing cross-disease comparisons through FAIR data practices to uncover shared molecular mechanisms between Alzheimer's disease and autoimmune disorders | NIH | National Institute on Aging | 2021 to 2025 | $14,514,376 | September 1, 2025 | April 30, 2027 | HEATH, LAURA MICHELLE | reporter.nih.gov |
| Integrative Pathways to Cognitive, Affective, and Brain Health | NIH | National Institute on Aging | 2022 to 2025 | $14,488,542 | September 30, 2022 | August 31, 2028 | RYFF, CAROL D. | reporter.nih.gov |
| FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $14,427,244 | March 1, 2020 | December 31, 2026 | BRODERICK, JOSEPH PAUL | reporter.nih.gov |
| Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks | NIH | National Institute on Aging | 2021 to 2024 | $14,414,001 | September 15, 2020 | August 31, 2025 | THOMPSON, PAUL M | reporter.nih.gov |
| Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study | NIH | National Institute on Aging | 2022 to 2025 | $14,339,100 | August 15, 2022 | July 31, 2028 | DEAL, JENNIFER ANNE | reporter.nih.gov |
| Mild Cognitive Impairment: A Prospective Community Study | NIH | National Institute on Aging | 2021 to 2025 | $14,337,476 | September 1, 2005 | April 30, 2026 | GANGULI, MARY | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Rounds 4.2 and 4.4 | NIH | National Institute on Aging | 2021 to 2025 | $14,285,263 | September 1, 2013 | February 28, 2027 | WAITE, LINDA J | reporter.nih.gov |
| The RADAR cohort study of multilevel Influences on HIV and substance use | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,251,651 | April 15, 2014 | April 30, 2030 | MUSTANSKI, BRIAN | reporter.nih.gov |
| Study of Healthy Aging in African Americans | NIH | National Institute on Aging | 2023 to 2025 | $14,240,222 | January 1, 2017 | May 31, 2028 | WHITMER, RACHEL A | reporter.nih.gov |
| The Mobile Toolbox for Monitoring Cognitive and Behavioral Function (MTB2) | NIH | National Institute on Aging | 2021 to 2024 | $14,206,304 | September 15, 2018 | May 31, 2029 | GERSHON, RICHARD | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2022 to 2023 | $14,187,625 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,117,524 | April 1, 2019 | September 30, 2026 | GUSTAFSON, DEBORAH R. | reporter.nih.gov |
| Vanderbilt Memory & Aging Project | NIH | National Institute on Aging | 2021 to 2025 | $14,019,775 | March 15, 2011 | March 31, 2027 | JEFFERSON, ANGELA L. | reporter.nih.gov |
| Sleep for Stroke Management And Recovery Trial (Sleep SMART) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $13,933,376 | August 15, 2018 | April 30, 2027 | BROWN, DEVIN L | reporter.nih.gov |
| HEAL ERN: Data Coordinating Resource Center | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $13,821,158 | September 23, 2022 | August 31, 2027 | WATT, KEVIN M | reporter.nih.gov |
| Multicultural Community Dementia Screening | NIH | National Institute on Aging | 2021 to 2025 | $13,797,203 | May 1, 2021 | January 31, 2027 | GALVIN, JAMES E | reporter.nih.gov |
| Wyoming Sensory Biology COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,747,906 | September 1, 2017 | July 31, 2027 | SUN, QIAN-QUAN | reporter.nih.gov |
| Arylepoxamides: A new class of potent, safer analgesics | NIH | National Institute on Drug Abuse | 2021 to 2023 | $13,729,307 | December 15, 2018 | August 31, 2025 | REICH, JEFFREY | reporter.nih.gov |
| Admin. Supp.: Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,703,967 | May 15, 2023 | April 30, 2028 | DOUDNA, JENNIFER A | reporter.nih.gov |
| 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | NIH | National Institute on Drug Abuse | 2021 to 2025 | $13,649,176 | September 30, 2015 | March 31, 2027 | YURGELUN-TODD, DEBORAH A. | reporter.nih.gov |
| A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimerʼs Disease | NIH | National Institute on Aging | 2021 | $13,634,548 | September 15, 2018 | May 31, 2024 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Center for the Study of Aphasia Recovery (C-STAR) | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $13,541,079 | April 1, 2016 | March 31, 2027 | FRIDRIKSSON, JULIUS | reporter.nih.gov |
| Lysosome Regulation and Signaling in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $13,495,371 | June 1, 2021 | February 28, 2027 | ZHENG, HUI | reporter.nih.gov |
| 1/2 ICECAP: Influence of Cooling duration on Efficacy in Cardiac Arrest Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,466,840 | September 19, 2019 | August 31, 2025 | MEURER, WILLIAM JOSEPH | reporter.nih.gov |
| 1Florida Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $13,348,245 | June 15, 2020 | April 30, 2027 | SMITH, GLENN E. | reporter.nih.gov |
| Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP) | NIH | National Institute on Aging | 2021 to 2025 | $13,310,071 | June 1, 2021 | March 31, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $13,305,831 | July 7, 2010 | March 31, 2029 | CORESH, JOSEF | reporter.nih.gov |
| Prevention of Fractures in Patients with Parkinson's Disease | NIH | National Institute on Aging | 2022 to 2024 | $13,269,734 | September 30, 2018 | February 28, 2026 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | NIH | National Institute on Drug Abuse | 2024 to 2025 | $13,234,516 | July 16, 2025 | July 15, 2026 | reporter.nih.gov | |
| BRAIN CONNECTS: The center for Large-scale Imaging of Neural Circuits (LINC) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,208,545 | September 1, 2023 | June 30, 2028 | YENDIKI, ANASTASIA | reporter.nih.gov |
| MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS | NIH | National Institute on Aging | 2021 to 2025 | $13,186,351 | September 1, 2020 | May 31, 2027 | AGGARWAL, NEELUM T. | reporter.nih.gov |
| Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Surveys in India (LASI) | NIH | National Institute on Aging | 2021 to 2025 | $13,167,007 | September 15, 2015 | April 30, 2026 | LEE, JINKOOK | reporter.nih.gov |
| Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,006,073 | September 25, 2019 | July 31, 2026 | CORCOS, DANIEL M. | reporter.nih.gov |
| Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood | NIH | National Institute on Aging | 2023 to 2025 | $12,972,426 | September 1, 2023 | May 31, 2028 | KARIKARI, THOMAS K | reporter.nih.gov |
| The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2023 | $12,937,549 | August 15, 2016 | April 30, 2024 | SPERLING, REISA A. | reporter.nih.gov |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,902,047 | September 30, 2021 | July 31, 2026 | BECKER, WILLIAM C | reporter.nih.gov |
| HEALTH Center for Addictions Research and Cancer Prevention | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $12,882,144 | September 8, 2020 | April 30, 2026 | BEECH, BETTINA M. | reporter.nih.gov |
| Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD) | NIH | National Institute of Mental Health | 2021 to 2024 | $12,719,359 | September 16, 2021 | August 31, 2025 | SMELSON, DAVID A | reporter.nih.gov |
| THE NIH NEUROBIOBANK AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,702,242 | May 1, 2025 | October 31, 2025 | BLANCHARD, THOMAS | reporter.nih.gov |
| Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | NIH | National Institute on Aging | 2022 to 2025 | $12,690,286 | April 15, 2017 | April 30, 2027 | KAPLAN, HILLARD S | reporter.nih.gov |
| Clinical Trial Data Processing, Analysis, and Coordination Center (CT-DPACC) for Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Project | NIH | National Institute of Mental Health | 2024 to 2025 | $12,671,179 | June 17, 2024 | May 31, 2029 | SHENTON, MARTHA E. | reporter.nih.gov |
| Tailored Retention and Engagement for Effective integrated Treatment of OUD and Pain (TREETOP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,656,947 | September 30, 2021 | July 31, 2027 | WINSTANLEY, ERIN L | reporter.nih.gov |
| Medicare at a Crossroads | NIH | National Institute on Aging | 2021 to 2025 | $12,593,170 | August 15, 2009 | April 30, 2030 | LANDON, BRUCE E. | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $12,591,952 | August 15, 2025 | July 31, 2029 | DETKE, MICHAEL J. | reporter.nih.gov |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects | NIH | National Institute on Aging | 2021 to 2022 | $12,573,346 | May 1, 2019 | February 28, 2023 | DIDSBURY, JOHN | reporter.nih.gov |
| Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,564,620 | September 1, 2021 | June 30, 2027 | KELLIS, MANOLIS | reporter.nih.gov |
| Duke Autism Center of Excellence: A translational digital health and computational approach to early identification, outcome monitoring, and biomarker discovery in autism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $12,545,063 | September 7, 2017 | August 31, 2027 | DAWSON, GERALDINE | reporter.nih.gov |
| Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $12,536,106 | February 15, 2022 | November 30, 2026 | MURRAY, MELISSA ERIN | reporter.nih.gov |
| Endophenotypes of Persistent Post-Concussive Symptoms in Adolescents: CARE4Kids | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $12,522,070 | September 8, 2021 | March 31, 2027 | GIZA, CHRISTOPHER C | reporter.nih.gov |
| Center for Addiction and Disease Risk Exacerbation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,487,946 | August 1, 2019 | July 31, 2029 | MONTI, PETER M. | reporter.nih.gov |
| Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan | NIH | National Institute on Aging | 2021 to 2024 | $12,295,034 | February 15, 2020 | November 30, 2025 | OTTMAN, RUTH | reporter.nih.gov |
| Autism Center of Excellence Network: Neurodevelopmental Biomarkers of Late Diagnosis in Autism | NIH | National Institute of Mental Health | 2021 to 2025 | $12,178,377 | September 4, 2012 | June 30, 2027 | PELPHREY, KEVIN A | reporter.nih.gov |
| Exploring Cognitive Aging Using Reference Ability Neural Networks | NIH | National Institute on Aging | 2021 to 2025 | $12,167,937 | September 1, 2011 | June 30, 2027 | STERN, YAAKOV | reporter.nih.gov |
| StrokeNet Thrombectomy Endovascular Platform (STEP) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $12,112,868 | September 1, 2022 | February 28, 2026 | ELM, JORDAN J. | reporter.nih.gov |
| Center for Research and Education on Aging and Technology Enhancement - CREATE | NIH | National Institute on Aging | 2022 to 2025 | $12,069,399 | June 15, 2022 | May 31, 2027 | CZAJA, SARA J | reporter.nih.gov |
| Advancing brain health research through male germline editing in marmosets | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,061,296 | August 1, 2021 | May 31, 2027 | HERMANN, BRIAN PETER | reporter.nih.gov |
| Center for Live Cell Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,992,289 | September 15, 2021 | June 30, 2027 | HAUSSLER, DAVID H | reporter.nih.gov |
| Alzheimers Disease Patient Registry (Administrative Supplement) | NIH | National Institute on Aging | 2021 to 2023 | $11,991,901 | September 30, 1986 | June 30, 2026 | PETERSEN, RONALD C | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| DIAN-TU: Next Generation Prevention Trial | NIH | National Institute on Aging | 2022 to 2023 | $11,960,034 | September 1, 2017 | May 31, 2024 | BATEMAN, RANDALL J | reporter.nih.gov |
| Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems. | NIH | National Institute on Aging | 2021 to 2025 | $11,898,685 | September 15, 2007 | May 31, 2029 | TRIVEDI, AMAL N. | reporter.nih.gov |
| I3C DECADE: Developmental Epidemiology of Childhood Cardiovascular Exposures and Alzheimer’s Dementia | NIH | National Institute on Aging | 2022 to 2025 | $11,889,015 | July 1, 2022 | April 30, 2028 | MACLEHOSE, RICHARD F | reporter.nih.gov |
| Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $11,846,278 | September 1, 2024 | August 31, 2028 | OSKARSSON, BJORN E | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| COBRE Center on Opioids and Overdose | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,768,169 | September 1, 2018 | August 31, 2028 | RICH, JOSIAH D | reporter.nih.gov |
| UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $11,668,134 | September 1, 2022 | August 31, 2027 | LEIN, PAMELA J | reporter.nih.gov |
| Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $11,652,217 | June 1, 2020 | March 31, 2026 | XIONG, CHENGJIE | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,639,047 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| Cancer Center Support (CORE) Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,628,123 | August 1, 1997 | June 30, 2030 | PALUCKA, ANNA KAROLINA | reporter.nih.gov |
| West Virginia University Stroke COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $11,604,264 | September 8, 2014 | May 31, 2026 | DEVRIES, ANNE COURTNEY | reporter.nih.gov |
| Early Life Adversity, Biological Embedding, and Risk for Developmental Precursors of Mental Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $11,595,410 | May 22, 2018 | May 31, 2028 | LUBY, JOAN L. | reporter.nih.gov |
| Kynurenine accumulation drives loss of muscle and bone function with aging | NIH | National Institute on Aging | 2021 to 2025 | $11,563,609 | May 1, 2011 | May 31, 2027 | ISALES, CARLOS M. | reporter.nih.gov |
| Estrogens, Cardiometabolic Health, and Female Cognitive Aging | NIH | National Institute on Aging | 2022 to 2025 | $11,521,268 | March 1, 2022 | February 28, 2027 | DANIEL, JILL M | reporter.nih.gov |
| Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,497,463 | May 15, 2022 | April 30, 2027 | DONG, HONG-WEI | reporter.nih.gov |
| Sleep in Neurocognitive Aging and Alzheimers Research (SANAR) | NIH | National Institute on Aging | 2021 to 2025 | $11,494,462 | February 1, 2021 | January 31, 2027 | RAMOS, ALBERTO RAFAEL | reporter.nih.gov |
| Impact of Neuroinflammation on AD Occurrence: A Bi-Generational Population Study | NIH | National Institute on Aging | 2021 to 2025 | $11,418,675 | September 1, 2021 | May 31, 2027 | RAJAN, KUMAR B. | reporter.nih.gov |
| Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry | NIH | National Institute on Aging | 2021 to 2025 | $11,411,820 | February 1, 2021 | January 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| A Longitudinal Brain and Behavior Study of Autism From Infancy Through Adolescence | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $11,410,066 | July 1, 2007 | August 31, 2027 | PIVEN, JOSEPH | reporter.nih.gov |
| Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $11,402,108 | September 30, 2004 | May 31, 2027 | BARNES, LISA L | reporter.nih.gov |
| Supplement to TR01 Human cortical development and neural plasticity altered by trisomy 21 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $11,380,369 | September 10, 2021 | August 31, 2027 | BHATTACHARYYA, ANITA | reporter.nih.gov |
| Complement Mediated Remodeling in Pulmonary Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $11,355,302 | August 1, 2020 | June 30, 2026 | STENMARK, KURT R. | reporter.nih.gov |
| Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline | NIH | National Institute on Aging | 2021 to 2024 | $11,354,079 | August 1, 2020 | July 31, 2025 | GUPTA, ADITI | reporter.nih.gov |
| Circuit-specific cell types in aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $11,340,010 | June 1, 2022 | May 31, 2028 | LEE, KUO-FEN | reporter.nih.gov |
| Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil | NIH | National Institute on Aging | 2023 to 2025 | $11,334,713 | August 15, 2023 | July 31, 2028 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| Center for Dissemination and Implementation At Stanford (C-DIAS) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $11,245,029 | August 1, 2022 | May 31, 2027 | MCGOVERN, MARK P | reporter.nih.gov |
| The Longitudinal Course of Imaging Biomarkers in People At Risk for Alzheimer’s Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,223,576 | August 15, 2004 | March 31, 2027 | JOHNSON, STERLING C | reporter.nih.gov |
| KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology | NIH | National Institute on Aging | 2021 to 2025 | $11,202,386 | August 15, 2021 | July 31, 2027 | SAYKIN, ANDREW J | reporter.nih.gov |
| Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,197,081 | September 30, 2021 | July 31, 2027 | RANA, TARIQ M | reporter.nih.gov |
| Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,194,636 | September 23, 2021 | August 31, 2027 | ROSENTHAL, JOSHUA J.C. | reporter.nih.gov |
| 1/4 Powering Genetic Discovery for Severe Mental Illness in Latin American and African Ancestries | NIH | National Institute of Mental Health | 2021 to 2024 | $11,112,946 | September 14, 2020 | July 31, 2025 | NEALE, BENJAMIN MICHAEL | reporter.nih.gov |
| Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,085,606 | May 15, 2021 | July 31, 2026 | KENNY, PAUL J. | reporter.nih.gov |
| Center for Neural Circuits in Addiction | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,925,897 | August 15, 2020 | May 31, 2030 | THOMAS, MARK JOHN | reporter.nih.gov |
| Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $10,898,840 | May 15, 2022 | April 30, 2027 | XU, XIANGMIN | reporter.nih.gov |
| A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $10,874,349 | April 1, 2019 | June 30, 2025 | FELDMAN, HOWARD | reporter.nih.gov |
| Center to Advance Research Excellence (OPTIC) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,836,251 | August 15, 2018 | June 30, 2028 | STEIN, BRADLEY D | reporter.nih.gov |
| 5/21 ABCD-USA Consortium: Research Project Site at UC San Diego | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,821,558 | September 30, 2015 | March 31, 2027 | TAPERT, SUSAN F. | reporter.nih.gov |
| Longitudinal Imaging Biomarkers of Prodromal DLB | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,821,041 | September 25, 2017 | August 31, 2027 | KANTARCI, KEJAL | reporter.nih.gov |
| Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR) | NIH | National Institute on Drug Abuse | 2025 | $10,685,838 | August 11, 2025 | August 10, 2026 | reporter.nih.gov | |
| Greater Intermountain Node (CTN-0138) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,595,733 | March 1, 2025 | February 29, 2032 | COCHRAN, GERALD T. | reporter.nih.gov |
| Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis | NIH | National Institute on Aging | 2024 to 2025 | $10,584,728 | September 30, 2008 | May 31, 2029 | BATEMAN, RANDALL J | reporter.nih.gov |
| Arterial Stiffness, Cognition, and Equol (ACE) | NIH | National Institute on Aging | 2022 to 2025 | $10,581,052 | February 15, 2022 | January 31, 2027 | SEKIKAWA, AKIRA | reporter.nih.gov |
| Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,550,278 | September 30, 2020 | July 31, 2026 | SPRINGER, SANDRA ANN | reporter.nih.gov |
| VCID Biomarkers Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $10,493,954 | September 30, 2016 | June 30, 2027 | GREENBERG, STEVEN M | reporter.nih.gov |
| The INCLUDE Project Down Syndrome Biorepository (DS-Biorepository) | NIH | National Institute on Aging | 2024 to 2025 | $10,436,444 | September 30, 2024 | August 31, 2029 | ESPINOSA, JOAQUIN M. | reporter.nih.gov |
| Mount Sinai ECHO site for Perinatal Environment and Development Studies | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $10,423,916 | September 21, 2016 | May 31, 2025 | WRIGHT, ROSALIND J | reporter.nih.gov |
| SPORE in Brain Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,413,880 | September 1, 2008 | August 31, 2029 | LANG, FREDERICK F | reporter.nih.gov |
| Growth and development of Striatal-Cerebellum circuitry in subjects at risk for Huntington’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,413,314 | March 1, 2009 | August 31, 2026 | NOPOULOS, PEGGY C | reporter.nih.gov |
| NIH StrokeNet National Clinical Coordinating Center (NCC) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,366,158 | September 30, 2013 | November 30, 2028 | BRODERICK, JOSEPH PAUL | reporter.nih.gov |
| Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. | NIH | National Institute on Aging | 2022 to 2025 | $10,320,460 | February 15, 2022 | January 31, 2027 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study | NIH | National Institute on Aging | 2021 to 2024 | $10,318,677 | April 15, 2019 | January 31, 2026 | ELY, E WESLEY | reporter.nih.gov |
| 9/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U MICHIGAN | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,318,458 | September 30, 2015 | March 31, 2027 | HEITZEG, MARY M | reporter.nih.gov |
| Cannabidiol in the treatment of opioid use disorder | NIH | National Institute on Drug Abuse | 2024 | $10,316,590 | September 30, 2019 | August 31, 2027 | HURD, YASMIN L. | reporter.nih.gov |
| 15/21 ABCD-USA Consortium: Research Project Site at LIBR | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,302,955 | April 15, 2020 | March 31, 2027 | PAULUS, MARTIN P. | reporter.nih.gov |
| Validation of Early Prognostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trials (VERIFY) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,302,336 | September 1, 2021 | July 1, 2025 | KHATRI, POOJA | reporter.nih.gov |
| Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa | NIH | National Institute on Aging | 2022 to 2025 | $10,293,481 | September 30, 2022 | August 31, 2027 | TOFAEONO, VAATAUSILI T | reporter.nih.gov |
| NIH Health Care Systems Research Collaboratory-Coordinating Center (U24) | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $10,249,994 | September 22, 2022 | May 31, 2028 | HERNANDEZ, ADRIAN | reporter.nih.gov |
| Vermont Center for Cardiovascular and Brain Health | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $10,185,844 | August 6, 2020 | May 31, 2026 | CUSHMAN, MARY | reporter.nih.gov |
| ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia | NIH | National Institute on Aging | 2022 to 2023 | $10,112,651 | September 1, 2022 | June 24, 2024 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| StATins Use in intRacerebral hemorrhage patieNts (SATURN) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,035,219 | September 1, 2019 | February 29, 2028 | SELIM, MAGDY H | reporter.nih.gov |
| 4/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT FIU | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,979,334 | September 30, 2015 | March 31, 2027 | GONZALEZ, RAUL | reporter.nih.gov |
| NEUROBIOBANK BRAIN AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,962,676 | May 1, 2025 | October 31, 2025 | LEWIS, DAVID | reporter.nih.gov |
| Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility | NIH | National Institute on Aging | 2021 to 2024 | $9,901,034 | May 1, 2021 | February 28, 2026 | REDLINE, SUSAN S. | reporter.nih.gov |
| LifeâÂÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial | NIH | National Institute on Aging | 2021 to 2022 | $9,892,823 | September 15, 2020 | April 30, 2026 | MINTZER, JACOBO | reporter.nih.gov |
| Gateway Exposome Coordinating Center (GECC) For AD/ADRD Research | NIH | National Institute on Aging | 2024 to 2025 | $9,887,007 | August 1, 2024 | July 31, 2029 | LEE, JINKOOK | reporter.nih.gov |
| PF614-MPAR: clinical development of opioid with oral overdose protection | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,861,616 | September 1, 2024 | May 31, 2027 | KIRKPATRICK, LYNN | reporter.nih.gov |
| Autism Genetics Phase II: Increasing Representation of Human Diversity | NIH | National Institute of Mental Health | 2021 to 2024 | $9,859,913 | March 25, 2013 | May 31, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $9,796,602 | March 1, 2024 | February 28, 2027 | SHNEIDER, NEIL ALAN | reporter.nih.gov |
| 21/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT WUSTL | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,776,479 | April 15, 2020 | March 31, 2027 | MADDEN, PAMELA ANN | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,737,772 | June 1, 2021 | May 31, 2027 | MORRELL, MARTHA J | reporter.nih.gov |
| Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,732,775 | August 1, 2024 | May 31, 2027 | SHAH, NIKEJ | reporter.nih.gov |
| Vanderbilt Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,726,538 | December 1, 1996 | March 31, 2027 | POWERS, ALVIN C | reporter.nih.gov |
| DEploying High ValuE LOngitudinal Population-Based dAta in Dementia Research (DEVELOP AD Research) | NIH | National Institute on Aging | 2021 to 2024 | $9,684,597 | September 30, 2020 | May 31, 2026 | MORRISON, R. SEAN | reporter.nih.gov |
| Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging) | NIH | National Institute on Aging | 2023 to 2025 | $9,673,461 | September 30, 2021 | August 31, 2027 | ROGALSKI, EMILY J | reporter.nih.gov |
| National Swine Resource and Research Center (NSRRC) Years 21-25 | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,635,041 | September 1, 2003 | July 31, 2028 | LEE, KIHO | reporter.nih.gov |
| TASK ORDER 1 - OCR PROJECT MANAGEMENT, DSMB AND CROMS-RELATED SUPPORT | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,613,167 | March 25, 2024 | March 24, 2026 | APPELMANS, ELINE | reporter.nih.gov |
| Collaborative Approach for Asian Americans, Native Hawaiians, and Pacific Islanders Research and Education (CARE) 2.0 | NIH | National Institute on Aging | 2023 to 2025 | $9,607,843 | August 1, 2023 | June 30, 2028 | PARK, VAN MY TA | reporter.nih.gov |
| Southern Consortium Node of the Clinical Trials Network (TMS for CUD) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,579,585 | March 1, 2025 | February 29, 2032 | BARTH, KELLY S. | reporter.nih.gov |
| M-SCORCH: Methamphetamine use disorder data generation center for Single Cell Opioid Responses in the Context of HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,490,616 | May 15, 2021 | February 28, 2027 | HO, YA-CHI | reporter.nih.gov |
| CNS Effects of Alcohol: Cellular Neurobiology | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $9,489,642 | December 1, 1983 | December 31, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study) | NIH | National Institute on Aging | 2022 to 2025 | $9,488,371 | August 1, 2022 | July 31, 2027 | ZHANG, RONG | reporter.nih.gov |
| Thin, High-Density, High-Performance, Depth and Surface Microelectrodes for Diagnosis and Treatment of Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,482,559 | September 1, 2021 | August 31, 2027 | DAYEH, SHADI | reporter.nih.gov |
| BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial | NIH | National Institute on Aging | 2021 to 2025 | $9,481,336 | February 15, 2021 | November 30, 2026 | HANLEY, DANIEL F | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2025 | $9,466,491 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $9,464,743 | February 1, 2019 | January 31, 2026 | RAMEY, SHARON LANDESMAN | reporter.nih.gov |
| Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $9,460,610 | September 6, 2022 | August 31, 2027 | VEENSTRA-VANDERWEELE, JEREMY | reporter.nih.gov |
| 1/3 Genomics of Schizophrenia in the South African Xhosa | NIH | National Institute of Mental Health | 2021 to 2025 | $9,460,283 | January 1, 2021 | December 31, 2026 | KING, MARY-CLAIRE | reporter.nih.gov |
| 2/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UMB | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,449,174 | September 30, 2015 | March 31, 2027 | ERNST, THOMAS M | reporter.nih.gov |
| Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,439,774 | March 10, 2016 | June 30, 2027 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABI | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,377,344 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order | NIH | National Institute on Aging | 2021 to 2024 | $9,373,073 | June 1, 2020 | March 31, 2026 | MAYEUX, RICHARD P | reporter.nih.gov |
| A novel therapeutic to ameliorate chronic pain and reduce opiate use | NIH | National Institute on Drug Abuse | 2021 to 2024 | $9,323,255 | March 15, 2019 | June 30, 2024 | TABAKOFF, BORIS | reporter.nih.gov |
| Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT) | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $9,296,510 | January 15, 2025 | December 31, 2026 | KAPUR, JAIDEEP | reporter.nih.gov |
| The San Antonio Heart and Mind Study | NIH | National Institute on Aging | 2023 to 2025 | $9,286,743 | July 1, 2023 | March 31, 2029 | SATIZABAL, CLAUDIA L | reporter.nih.gov |
| African Americans Fighting Alzheimer’s in Midlife (AA-FAIM) | NIH | National Institute on Aging | 2021 to 2025 | $9,250,399 | August 1, 2016 | November 30, 2027 | GLEASON, CAREY E | reporter.nih.gov |
| Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimer’s disease pathogenesis in the BEACoN Cohort | NIH | National Institute on Aging | 2021 to 2025 | $9,240,061 | August 1, 2017 | December 31, 2027 | YASSA, MICHAEL A | reporter.nih.gov |
| Development of a novel drug for treating opioid use disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $9,160,866 | March 15, 2019 | August 31, 2025 | SHAH, NIKEJ | reporter.nih.gov |
| The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19 | NIH | National Institute on Aging | 2022 to 2024 | $9,143,854 | June 15, 2022 | May 31, 2026 | POSSIN, KATHERINE LAUREL | reporter.nih.gov |
| HIV Center for Clinical and Behavioral Studies | NIH | National Institute of Mental Health | 2021 to 2025 | $9,131,244 | September 30, 1987 | April 30, 2028 | REMIEN, ROBERT H | reporter.nih.gov |
| GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $9,120,320 | September 6, 2022 | August 31, 2027 | VOLK, HEATHER E | reporter.nih.gov |
| Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $9,111,057 | July 1, 2019 | April 30, 2027 | SHETH, KEVIN NAVIN | reporter.nih.gov |
| Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,106,321 | September 29, 2021 | August 31, 2026 | DONNELLY, CHRISTOPHER JAMES | reporter.nih.gov |
| Center of Excellence in Environmental Toxicology | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $9,096,433 | April 1, 2006 | May 31, 2030 | PENNING, TREVOR M | reporter.nih.gov |
| Resilience and brain health of older adults | NIH | National Institute on Aging | 2021 to 2025 | $9,066,206 | August 15, 2021 | May 31, 2027 | LENZE, ERIC J | reporter.nih.gov |
| University of New Mexico (UNM) Center for Brain Recovery and Repair | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $9,061,444 | September 15, 2015 | June 30, 2026 | SHUTTLEWORTH, CLAUDE W | reporter.nih.gov |
| Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities | NIH | National Institute of Mental Health | 2021 to 2023 | $9,060,652 | June 17, 2013 | March 31, 2025 | BARAM, TALLIE Z. | reporter.nih.gov |
| Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers | NIH | National Institute on Drug Abuse | 2023 to 2025 | $9,048,057 | September 30, 2023 | August 31, 2026 | COSFORD, NICHOLAS DAVID | reporter.nih.gov |
| NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease | NIH | National Institute of Mental Health | 2023 to 2025 | $9,005,480 | August 23, 2023 | August 22, 2026 | HADIJAH, VACTOR | reporter.nih.gov |
| Epidemiologic Study of Neural Reserve and Neurobiology of Aging | NIH | National Institute on Aging | 2021 to 2023 | $8,995,869 | September 30, 2001 | May 31, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes | NIH | National Institute on Aging | 2021 to 2025 | $8,986,759 | June 1, 2020 | August 31, 2030 | JOFFE, HADINE | reporter.nih.gov |
| Prevention Research Center: Parenting Among Women Who Are Opioid Users | NIH | National Institute on Drug Abuse | 2021 to 2023 | $8,972,150 | August 15, 2019 | May 31, 2025 | LEVE, LESLIE DIANE | reporter.nih.gov |
| TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024. | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,957,809 | August 30, 2023 | August 29, 2026 | ROTH, BRYAN | reporter.nih.gov |
| Identifying the genetic causes of depression in a deeply phenotyped population from South Korea | NIH | National Institute of Mental Health | 2021 to 2025 | $8,898,757 | August 17, 2021 | June 30, 2027 | FLINT, JONATHAN | reporter.nih.gov |
| Consequences of Incarceration on Health, Age-Related Conditions, and Risk Factors for ADRD | NIH | National Institute on Aging | 2024 to 2025 | $8,887,003 | August 15, 2024 | April 30, 2029 | TEPLIN, LINDA A | reporter.nih.gov |
| Molecular and Circuit Pathogenesis of Alcohol Use Disorders | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,884,347 | December 1, 1997 | November 30, 2027 | KASH, THOMAS L. | reporter.nih.gov |
| Biospecimen Exchange for Neurological Disorders (BioSEND) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,861,360 | August 1, 2021 | July 31, 2027 | FOROUD, TATIANA M. | reporter.nih.gov |
| Center for Genetic Studies of Drug Abuse in Outbred Rats | NIH | National Institute on Drug Abuse | 2021 to 2023 | $8,856,132 | June 15, 2014 | April 30, 2025 | PALMER, ABRAHAM A | reporter.nih.gov |
| Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN Supplement | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,842,412 | July 1, 2016 | June 30, 2023 | HANLEY, DANIEL F | reporter.nih.gov |
| Translational Platform for Epilepsy Therapy and Biomarker Discovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,833,081 | April 15, 2022 | March 31, 2027 | GALANOPOULOU, ARISTEA S | reporter.nih.gov |
| 7/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT YALE | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,739,227 | September 30, 2015 | March 31, 2027 | BASKIN-SOMMERS, ARIELLE RYAN | reporter.nih.gov |
| Multiscale functional characterization of genomic variation in human developmental disorders | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,736,987 | September 1, 2021 | May 31, 2027 | HON, GARY CHUNG | reporter.nih.gov |
| Risk Factors, Pathology, and Clinical Expressions of AD | NIH | National Institute on Aging | 2021 to 2024 | $8,703,055 | July 15, 1998 | April 30, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge Translation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,690,640 | July 15, 2015 | April 30, 2030 | SCHACKMAN, BRUCE R | reporter.nih.gov |
| Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $8,683,509 | September 30, 2022 | July 31, 2025 | TOLL, LAWRENCE R | reporter.nih.gov |
| 19/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UVM | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,669,646 | April 15, 2020 | March 31, 2027 | GARAVAN, HUGH P. | reporter.nih.gov |
| Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions | NIH | National Institute on Aging | 2021 to 2025 | $8,654,669 | July 1, 2021 | June 30, 2027 | TEMPLE, SALLY | reporter.nih.gov |
| Public Health and Autism Science advancing Effectual Strategies across the life course (PHASES) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $8,623,178 | September 6, 2022 | August 31, 2027 | ROBINS, DIANA L | reporter.nih.gov |
| Revisiting ReCHARGE: ECHO Follow up on Middle Childhood and Adolescence | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,577,337 | September 21, 2016 | May 31, 2030 | HERTZ-PICCIOTTO, IRVA | reporter.nih.gov |
| TCN PATHS Supplemental funding | NIH | National Institute on Drug Abuse | 2021 to 2024 | $8,572,442 | July 15, 2019 | April 30, 2026 | WANG, EMILY AI-HUA | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2023 to 2024 | $8,554,832 | May 15, 2019 | February 28, 2026 | WARREN, JOHN ROBERT | reporter.nih.gov |
| P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in India | NIH | National Institute on Aging | 2024 to 2025 | $8,548,820 | September 15, 2024 | August 31, 2029 | NARAYAN, KABAYAM M VENKAT | reporter.nih.gov |
| Alzheimer variants: Propagation of shared functional changes across cellular networks | NIH | National Institute on Aging | 2021 to 2025 | $8,542,236 | July 15, 2021 | June 30, 2027 | DE JAGER, PHILIP L | reporter.nih.gov |
| MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022 | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,499,200 | September 1, 2002 | July 31, 2028 | MCRAE-CLARK, AIMEE L | reporter.nih.gov |
| A Latin American biobank for large-scale genetics research on severe mental illness | NIH | National Institute of Mental Health | 2021 to 2025 | $8,484,875 | May 1, 2020 | February 28, 2026 | FREIMER, NELSON B. | reporter.nih.gov |
| Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $8,481,225 | September 1, 2022 | August 31, 2027 | AMIN, RAOUF S. | reporter.nih.gov |
| Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man | NIH | National Institute on Drug Abuse | 2024 to 2025 | $8,480,887 | September 30, 2019 | April 30, 2027 | GRIGSON, PATRICIA SUE | reporter.nih.gov |
| Preserving Cognitive Resilience: A Biracial Parent-Offspring Study | NIH | National Institute on Aging | 2022 to 2024 | $8,461,054 | March 1, 2019 | May 31, 2026 | RAJAN, KUMAR B. | reporter.nih.gov |
| Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models | NIH | National Institute on Aging | 2021 to 2025 | $8,376,812 | July 1, 2021 | June 30, 2026 | SHULMAN, JOSHUA M | reporter.nih.gov |
| Genetic Architecture of Alzheimer’s disease Proteinopathies | NIH | National Institute on Aging | 2021 to 2024 | $8,376,544 | April 15, 2021 | February 28, 2026 | KAMBOH, M. ILYAS | reporter.nih.gov |
| Genetic Studies of Alzheimer's Disease in Jewish and Arab Populations | NIH | National Institute on Aging | 2023 to 2025 | $8,372,205 | September 1, 2023 | August 31, 2028 | FARRER, LINDSAY A. | reporter.nih.gov |
| Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $8,348,817 | September 15, 2022 | May 31, 2027 | ALBER, JESSICA | reporter.nih.gov |
| REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,345,645 | September 10, 2022 | July 31, 2027 | SAFFORD, MONIKA M | reporter.nih.gov |
| IMPACT-MH: Clinical and behavioral fingerprints of psychopathology | NIH | National Institute of Mental Health | 2024 to 2025 | $8,309,045 | August 12, 2024 | May 31, 2026 | PITTENGER, CHRISTOPHER JOHN | reporter.nih.gov |
| ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA | NIH | National Institute on Aging | 2022 to 2025 | $8,306,361 | June 15, 2022 | March 31, 2027 | MESULAM, MAREK-MARSEL M | reporter.nih.gov |
| Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies | NIH | National Institute on Aging | 2021 to 2025 | $8,305,058 | July 1, 2021 | June 30, 2026 | MONTINE, THOMAS J | reporter.nih.gov |
| 3/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U MINNESOTA | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,298,588 | September 30, 2015 | March 31, 2027 | LUCIANA, MONICA | reporter.nih.gov |
| Exceptional Longevity Data Management and Coordinating Center | NIH | National Institute on Aging | 2022 to 2025 | $8,296,806 | September 1, 2022 | July 31, 2027 | VARMA, SUSHEEL | reporter.nih.gov |
| A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $8,293,749 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| MRI Based Presymptomatic Prediction of ASD | NIH | National Institute of Mental Health | 2021 to 2024 | $8,292,562 | March 16, 2024 | January 31, 2026 | PRUETT, JOHN R | reporter.nih.gov |
| Washington University Intellectual and Developmental Disabilities Research Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $8,281,463 | July 28, 2020 | May 31, 2027 | DOUGHERTY, JOSEPH D | reporter.nih.gov |
| Gulf Coast Center for Precision Environmental Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $8,275,327 | May 15, 2019 | May 31, 2029 | WALKER, CHERYL L. | reporter.nih.gov |
| 6/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT OHSU | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,270,799 | September 30, 2015 | March 31, 2027 | NAGEL, BONNIE J. | reporter.nih.gov |
| Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,267,463 | September 1, 2022 | August 31, 2026 | THOMAS, ROBERT JOSEPH | reporter.nih.gov |
| Sex-based Differences in Glioma | NIH | National Cancer Institute | 2021 to 2025 | $8,258,328 | September 14, 2020 | December 31, 2026 | LATHIA, JUSTIN D. | reporter.nih.gov |
| Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials | NIH | National Institute on Aging | 2021 to 2023 | $8,244,109 | February 1, 2019 | January 31, 2025 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,243,787 | August 15, 2021 | June 30, 2027 | FOX, HOWARD S | reporter.nih.gov |
| Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $8,242,506 | August 15, 2020 | April 30, 2026 | ZHAN, CHANG-GUO | reporter.nih.gov |
| The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,227,499 | September 1, 2021 | August 31, 2027 | PHATNANI, HEMALI | reporter.nih.gov |
| COBRE in Stroke Recovery Administrative Supplement - Team Science | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $8,212,817 | June 2, 2014 | March 31, 2025 | KAUTZ, STEVEN A. | reporter.nih.gov |
| GLASS-AD: Global Latinos Sequencing Study for Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2025 | $8,212,071 | September 30, 2023 | August 31, 2028 | TOSTO, GIUSEPPE | reporter.nih.gov |
| Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,210,604 | February 1, 2016 | July 31, 2027 | ROSAND, JONATHAN | reporter.nih.gov |
| Tailored Non-Pharmacotherapy Services for Chronic Pain: Testing Scalable and Pragmatic Approaches - Admin Supplement | NIH | National Institute on Aging | 2021 to 2023 | $8,205,902 | September 30, 2019 | August 31, 2025 | DEBAR, LYNN L. | reporter.nih.gov |
| Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,189,971 | September 15, 2024 | August 31, 2026 | GITLER, AARON D. | reporter.nih.gov |
| Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone? | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,178,365 | September 30, 2019 | August 31, 2026 | KAMPMAN, KYLE MATTHEW | reporter.nih.gov |
| Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention | NIH | National Institute on Aging | 2022 to 2025 | $8,173,947 | July 1, 2022 | June 30, 2027 | ZARZAUR, BEN L | reporter.nih.gov |
| Disordered Proteostasis as a Driver of Disease in the Aging Lung | NIH | National Institute on Aging | 2021 to 2024 | $8,161,610 | July 1, 2015 | March 31, 2025 | BUDINGER, GR SCOTT | reporter.nih.gov |
| 14/21 ABCD-USA Consortium: Research Project Site at CU Boulder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,148,103 | April 15, 2020 | March 31, 2027 | BANICH, MARIE T | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial | NIH | National Institute on Aging | 2021 to 2022 | $8,118,116 | April 1, 2017 | September 30, 2024 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| Racial/Ethnic Disparities in ADRD Risk: The Impact of Social Relations | NIH | National Institute on Aging | 2021 to 2024 | $8,105,276 | June 1, 2020 | March 31, 2026 | ANTONUCCI, TONI CLAUDETTE | reporter.nih.gov |
| The Psychiatric Cell Map Initiative: Connecting Genomics, Subcellular Networks, and Higher Order Phenotypes | NIH | National Institute of Mental Health | 2021 to 2022 | $8,086,271 | September 5, 2018 | June 30, 2023 | KROGAN, NEVAN J | reporter.nih.gov |
| Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2025 | $8,050,699 | April 1, 2021 | January 31, 2027 | CRAWFORD, GREGORY E | reporter.nih.gov |
| Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries | NIH | National Institute on Aging | 2024 to 2025 | $8,032,655 | September 30, 2024 | August 31, 2029 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project | NIH | National Institute on Aging | 2022 to 2025 | $7,983,648 | June 1, 2022 | May 31, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan | NIH | National Institute of Mental Health | 2022 to 2025 | $7,973,681 | February 1, 2022 | November 30, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation | NIH | National Institute of Mental Health | 2021 to 2024 | $7,968,668 | February 1, 2020 | April 24, 2025 | GOLDSTEIN, JILL M | reporter.nih.gov |
| 1/4 Asian Bipolar Genetics Network (A-BIG-NET) | NIH | National Institute of Mental Health | 2022 to 2025 | $7,964,900 | September 19, 2022 | July 31, 2027 | HUANG, HAILIANG | reporter.nih.gov |
| Indiana Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,959,091 | July 6, 2015 | May 31, 2030 | EVANS-MOLINA, CARMELLA | reporter.nih.gov |
| INCLUDE Down Syndrome Clinical Cohort Coordinating Center (DS-4C) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $7,956,250 | September 20, 2024 | August 31, 2029 | HUNTER, JESSICA EZZELL | reporter.nih.gov |
| THE NIH PRECISION BRAIN HEALTH NETWORK: Open and Inclusive Measurement of Neuropsychological Change for AD/ADRD Primary Prevention Trials | NIH | National Institute on Aging | 2025 | $7,948,867 | August 1, 2025 | July 31, 2030 | SLIWINSKI, MARTIN J | reporter.nih.gov |
| Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community Supervision | NIH | National Institute on Drug Abuse | 2021 to 2024 | $7,947,350 | August 1, 2019 | April 30, 2025 | MARTIN, ROSEMARIE A | reporter.nih.gov |
| Development of SBS-226, a MOR agonist / DOR antagonist, for OUD | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,941,988 | September 30, 2024 | August 31, 2027 | REICH, JEFFREY | reporter.nih.gov |
| 20/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT VCU | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,897,207 | April 15, 2020 | March 31, 2027 | BJORK, JAMES M | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2023 to 2025 | $7,878,167 | September 15, 2017 | August 31, 2028 | ROGALSKI, EMILY J | reporter.nih.gov |
| Development of the novel mu-opioid receptor antagonist methocinnamox (MCAM) for preventing relapse and overdose | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,874,666 | August 15, 2024 | December 31, 2027 | FRANCE, CHARLES P | reporter.nih.gov |
| Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,828,464 | September 1, 2015 | May 31, 2027 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Greater Southern California Node of the Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,788,993 | June 1, 2019 | February 29, 2032 | MOONEY, LARISSA JEANETTE | reporter.nih.gov |
| Claude D. Pepper Older Americans Independence Center at Yale | NIH | National Institute on Aging | 2021 to 2025 | $7,769,010 | September 30, 2002 | June 30, 2028 | GILL, THOMAS MICHAEL | reporter.nih.gov |
| ERICH-GENE | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,768,356 | August 1, 2010 | June 30, 2025 | DEMEL, STACIE | reporter.nih.gov |
| The POINTER Neurovascular Ancillary Study | NIH | National Institute on Aging | 2021 to 2024 | $7,761,498 | April 15, 2020 | December 31, 2025 | BRINKLEY, TINA E | reporter.nih.gov |
| Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $7,757,977 | July 1, 2021 | June 30, 2027 | KAYED, RAKEZ | reporter.nih.gov |
| Comparing Treatment Approaches to Promote Inpatient Rehabilitation Effectiveness for Traumatic Brain Injury (CARE 4 TBI) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $7,746,716 | September 15, 2021 | August 31, 2028 | BOGNER, JENNIFER A | reporter.nih.gov |
| Columbia Center for Children's Environmental Health in ECHO II: Impact of environmental exposures on children's health and the co-morbidity of asthma and ADHD. | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $7,746,645 | September 21, 2016 | May 31, 2025 | HERBSTMAN, JULIE BETH | reporter.nih.gov |
| Mapping the vulnerable locus coeruleus pathways in aging and AD | NIH | National Institute on Aging | 2022 to 2025 | $7,731,727 | August 15, 2022 | July 31, 2027 | CHUNG, KWANGHUN | reporter.nih.gov |
| Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $7,715,052 | August 15, 2020 | July 31, 2025 | COSFORD, NICHOLAS DAVID | reporter.nih.gov |
| Behavioral Phenoscreening: Remote Assessment of Child Mental Health (REACH) | NIH | National Institute of Mental Health | 2025 | $7,684,671 | September 1, 2025 | August 31, 2029 | THOMASON, MORIAH E | reporter.nih.gov |
| Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment | NIH | National Institute on Drug Abuse | 2021 to 2023 | $7,640,612 | May 1, 2023 | April 30, 2026 | GORDON, MICHAEL SCOTT | reporter.nih.gov |
| SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging | NIH | National Institute on Aging | 2021 to 2025 | $7,600,838 | May 1, 2020 | April 30, 2027 | JAGUST, WILLIAM J. | reporter.nih.gov |
| Vietnamese Insights into Cognitive Aging Program (VIP) | NIH | National Institute on Aging | 2021 to 2025 | $7,598,841 | February 15, 2021 | May 31, 2026 | MEYER, OANH L | reporter.nih.gov |
| Reducing Opioid Mortality in Illinois (ROMI) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $7,594,077 | July 15, 2019 | April 30, 2025 | POLLACK, HAROLD ALEXANDER | reporter.nih.gov |
| Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD | NIH | National Institute on Aging | 2021 to 2025 | $7,592,411 | August 15, 2021 | May 31, 2027 | UDEH-MOMOH, CHINEDU THERESA | reporter.nih.gov |
| Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,571,345 | December 1, 1996 | December 31, 2027 | KAHN, STEVEN EMANUEL | reporter.nih.gov |
| Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia | NIH | National Institute on Aging | 2023 to 2025 | $7,564,979 | September 15, 2023 | May 31, 2028 | GALAMA, TITUS JOHANNES | reporter.nih.gov |
| ACE-D: Accelerating Cognition-guided signatures to Enhance translation in Depression | NIH | National Institute of Mental Health | 2024 to 2025 | $7,556,428 | May 3, 2024 | February 28, 2029 | WILLIAMS, LEANNE | reporter.nih.gov |
| THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITE(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,530,975 | May 1, 2025 | October 31, 2025 | SCOTT, WILLIAM | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| A major contributor of serious multisystem disease in the elderly: varicella zoster virus-induced inflammation | NIH | National Institute on Aging | 2021 to 2023 | $7,526,233 | March 1, 2009 | December 31, 2025 | NAGEL, MARIA ACENA | reporter.nih.gov |
| Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 | $7,523,227 | September 15, 2022 | August 31, 2025 | SHADYAB, ALADDIN | reporter.nih.gov |
| REpeated ASseSsmEnt of SurvivorS in ICH (REASSESS ICH) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $7,516,765 | January 1, 2022 | December 31, 2027 | ZIAI, WENDY C | reporter.nih.gov |
| Health Systems Node of the NIDA Clinical Trials Network (CTN Project: CTN-141 Hlth Ins Instability) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,514,766 | March 1, 2025 | February 29, 2032 | CAMPBELL, CYNTHIA I | reporter.nih.gov |
| Pediatric Dose Optimization for Seizures in EMS (PediDOSE) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $7,509,102 | August 1, 2021 | November 30, 2023 | SHAH, MANISH ISHWAR | reporter.nih.gov |
| Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $7,493,043 | June 1, 2017 | February 28, 2027 | MCKINNEY, CHRISTY MICHELLE | reporter.nih.gov |
| Indigenous Cultural Understandings of Alzheimer's Disease and Related Dementias - Research and Engagement (I-CARE) | NIH | National Institute on Aging | 2021 to 2025 | $7,489,463 | March 1, 2021 | February 28, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $7,486,964 | February 15, 2020 | January 31, 2026 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,434,979 | June 1, 2023 | February 29, 2028 | RANA, TARIQ M | reporter.nih.gov |
| A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients | NIH | National Institute on Aging | 2021 to 2022 | $7,416,643 | September 15, 2020 | May 31, 2023 | MOEBIUS, HANS JOERG | reporter.nih.gov |
| Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience | NIH | National Institute on Aging | 2021 to 2024 | $7,413,273 | September 15, 2020 | May 31, 2025 | SESHADRI, SUDHA | reporter.nih.gov |
| Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD). | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,405,564 | March 1, 2024 | November 30, 2027 | DEVARNEY, KATHERINE BEEBE | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2023 to 2024 | $7,403,993 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,389,501 | January 15, 2021 | December 31, 2026 | RAO, STEPHEN MARK | reporter.nih.gov |
| Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders | NIH | National Institute on Aging | 2021 to 2025 | $7,375,647 | July 1, 2021 | December 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| Neurodevelopmental Mechanisms Underlying Stress Vulnerability during Adolescence | NIH | National Institute of Mental Health | 2021 to 2024 | $7,374,581 | July 1, 2020 | April 30, 2025 | MCLAUGHLIN, KATIE | reporter.nih.gov |
| Predicting and Optimizing Language Outcomes in Minimally Verbal Children with Autism Spectrum Disorder | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $7,366,154 | September 1, 2019 | August 31, 2025 | TAGER-FLUSBERG, HELEN | reporter.nih.gov |
| Western States Node of the National Drug Abuse Treatment Clinical Trials Network (CTN-139) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,354,769 | March 1, 2025 | March 1, 2032 | KORTHUIS, PHILIP TODD | reporter.nih.gov |
| Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework | NIH | National Institute on Aging | 2022 to 2025 | $7,350,257 | February 15, 2022 | November 30, 2027 | COHEN, ANN D. | reporter.nih.gov |
| ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $7,328,850 | September 21, 2016 | August 31, 2024 | LESTER, BARRY M. | reporter.nih.gov |
| Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II) | NIH | National Institute on Aging | 2024 to 2025 | $7,286,036 | June 15, 2024 | November 30, 2029 | JOHNSON-AKEJU, OLUWASEUN | reporter.nih.gov |
| Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $7,285,275 | September 1, 2022 | August 31, 2024 | AMIN, RAOUF S. | reporter.nih.gov |
| Leveraging the 24-hour movement paradigm to preserve cognitive function and prevent Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis (MESA) 24H-ACT Study | NIH | National Institute on Aging | 2021 to 2024 | $7,263,372 | May 1, 2021 | April 30, 2026 | DIAZ, KEITH M | reporter.nih.gov |
| Early Life Stress and the Environmental Origins of Disease: a Population-based Prospective Longitudinal Study of Children in Rural Poverty (ECHO) | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $7,262,121 | September 21, 2016 | August 31, 2024 | TRASANDE, LEONARDO | reporter.nih.gov |
| The VETSA Longitudinal MRI Twin Study of Aging (VETSA MRI 4) | NIH | National Institute on Aging | 2022 to 2025 | $7,252,240 | June 1, 2022 | March 31, 2027 | ELMAN, JEREMY A | reporter.nih.gov |
| SUPPORT THE ONGOING OPERATIONS OF THE NATIONAL DATABASE FOR AUTISM RESEARCH - NDAR | NIH | National Institute on Drug Abuse | 2021 | $7,242,156 | January 1, 2021 | March 31, 2021 | GOODWIN, JOHN | reporter.nih.gov |
| Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging | NIH | National Institute on Aging | 2022 to 2025 | $7,239,829 | August 15, 2022 | June 30, 2027 | CRUCHAGA, CARLOS | reporter.nih.gov |
| Genetic Architecture of Early-Onset Psychosis in Mexicans (EPIMex) | NIH | National Institute of Mental Health | 2023 to 2025 | $7,156,776 | July 14, 2023 | May 31, 2028 | GLAHN, DAVID C | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer''s disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2025 | $7,155,353 | September 1, 2019 | April 30, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,153,018 | July 1, 2021 | June 30, 2027 | ZHI, DEGUI | reporter.nih.gov |
| Neuroplasticity-Based Computerized Cognitive Remediation (nCCR) for Treatment Resistant Late-Life Depression | NIH | National Institute of Mental Health | 2021 to 2025 | $7,151,191 | April 15, 2021 | February 28, 2027 | MORIMOTO, SARAH SHIZUKO | reporter.nih.gov |
| Escitalopram for Agitation in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2022 | $7,145,681 | September 30, 2016 | May 31, 2024 | LYKETSOS, CONSTANTINE G | reporter.nih.gov |
| Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,084,951 | May 15, 2023 | March 31, 2028 | NDHLOVU, LISHOMWA C | reporter.nih.gov |
| Action for Health in Diabetes (Look AHEAD) Extended Follow-up (LA-E2) | NIH | National Institute on Aging | 2021 to 2025 | $7,064,037 | August 1, 2021 | July 31, 2027 | ESPELAND, MARK ANDREW | reporter.nih.gov |
| Developing a NAMPT activator for Alzheimer’s disease | NIH | National Institute on Aging | 2023 to 2025 | $7,056,557 | September 15, 2023 | August 31, 2028 | CHEN, BEIBEI | reporter.nih.gov |
| Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $7,048,922 | March 15, 2023 | February 28, 2027 | BUSL, KATHARINA MARIA | reporter.nih.gov |
| PREcision Care In Cardiac ArrEst - ICECAP (PRECICECAP) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $7,046,260 | December 15, 2020 | April 30, 2026 | HIRSCH, KAREN G | reporter.nih.gov |
| A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,041,006 | June 1, 2021 | March 31, 2027 | SCHERRER, GREGORY | reporter.nih.gov |
| Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2023 | $7,036,460 | September 15, 2019 | May 31, 2025 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Autism Genetics Phase II: Increasing Representation of Human Diversity | NIH | National Institute of Mental Health | 2025 | $7,009,385 | March 25, 2013 | May 31, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $6,997,609 | May 1, 2021 | October 31, 2024 | ADEOYE, OPEOLU M | reporter.nih.gov |
| COBRE in Neurodevelopment and Its Disorders | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $6,991,499 | April 1, 2023 | February 29, 2028 | COWAN, CHRISTOPHER W | reporter.nih.gov |
| Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts. | NIH | National Institute on Aging | 2021 to 2022 | $6,989,910 | September 1, 2020 | August 31, 2025 | ERTEKIN-TANER, NILUFER | reporter.nih.gov |
| University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC) | NIH | National Institute on Aging | 2021 to 2025 | $6,970,364 | September 15, 2006 | June 30, 2027 | RYAN, ALICE S. | reporter.nih.gov |
| UCSF Older Americans Independence Center | NIH | National Institute on Aging | 2021 to 2025 | $6,946,581 | July 15, 2013 | June 30, 2028 | COVINSKY, KENNETH E. | reporter.nih.gov |
| Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models | NIH | National Institute on Aging | 2023 to 2025 | $6,945,316 | July 1, 2023 | March 31, 2028 | COBOS, INMA | reporter.nih.gov |
| Differential Effects of Exercise Modality on Cognition and Brain in Older Adults | NIH | National Institute on Aging | 2021 to 2025 | $6,923,080 | April 1, 2021 | March 31, 2027 | VIDONI, ERIC DENNIS | reporter.nih.gov |
| Risk Factors for Future Cognitive Decline and Alzheimers Disease in Older African Americans | NIH | National Institute on Aging | 2021 to 2025 | $6,919,789 | May 15, 2018 | May 31, 2028 | GLUCK, MARK A | reporter.nih.gov |
| Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,908,458 | July 15, 2021 | June 30, 2027 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Lifetime stressors and Alzheimer's Disease genetic variants and biomarkers in relation to cognitive decline among Black Women'sHealth Study participants. | NIH | National Institute on Aging | 2024 to 2025 | $6,906,113 | February 15, 2024 | January 31, 2029 | ROSENBERG, LYNN | reporter.nih.gov |
| Development of sigma receptor/DAT dual-targeting compounds to treat stimulant use disorder | NIH | National Institute on Drug Abuse | 2023 to 2024 | $6,903,733 | August 15, 2023 | July 31, 2026 | REICH, JEFFREY | reporter.nih.gov |
| Toward Healthy Aging in Adults with Autism: A Longitudinal Clinical and Multimodal Brain Imaging Study | NIH | National Institute of Mental Health | 2022 to 2024 | $6,900,037 | September 6, 2022 | June 30, 2027 | LAINHART, JANET ELIZABETH | reporter.nih.gov |
| Person-centered quality measurement and management in a system for addictions treatment in New York State | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,873,344 | September 30, 2023 | August 31, 2028 | NEIGHBORS, CHARLES J | reporter.nih.gov |
| A Longitudinal MRI Study Characterizing Very Early Brain Development in Infants with Down Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $6,871,845 | September 20, 2018 | August 31, 2025 | MARRUS, NATASHA | reporter.nih.gov |
| Clinical trials to prevent Alzheimer's Disease in Down Syndrome | NIH | National Institute on Aging | 2022 to 2024 | $6,863,895 | September 15, 2019 | August 31, 2025 | RAFII, MICHAEL S | reporter.nih.gov |
| GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $6,827,181 | June 1, 2022 | May 31, 2027 | WATTERSON, DANIEL MARTIN | reporter.nih.gov |
| Duke HEAL R-DEC | NIH | Office of the Director, National Institutes of Health | 2022 to 2023 | $6,823,028 | September 23, 2022 | June 30, 2025 | HORNIK, CHRISTOPH | reporter.nih.gov |
| Increasing financial and health equity among low income black youth and young adults | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $6,783,115 | September 23, 2021 | April 30, 2027 | LIPPMAN, SHERI ANN | reporter.nih.gov |
| The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease | NIH | National Institute on Aging | 2023 to 2025 | $6,770,771 | May 15, 2023 | January 31, 2028 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. | NIH | National Cancer Institute | 2021 to 2025 | $6,769,276 | March 1, 2021 | August 31, 2027 | KAHALLEY, LISA SCHUM | reporter.nih.gov |
| Examining the Persistence of Neurocognitive Benefits of Exercise | NIH | National Institute on Aging | 2023 to 2025 | $6,759,799 | September 1, 2023 | May 31, 2028 | ERICKSON, KIRK I | reporter.nih.gov |
| Artificial Intelligence Strategies for Alzheimer's Disease Research | NIH | National Institute on Aging | 2022 to 2025 | $6,749,268 | September 30, 2021 | August 31, 2026 | MOORE, JASON H. | reporter.nih.gov |
| North Carolina Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,742,732 | April 7, 2020 | May 31, 2028 | NEUFER, P DARRELL | reporter.nih.gov |
| 18/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT THE UNIVERSITY OF FLORIDA | NIH | National Institute on Drug Abuse | 2021 to 2025 | $6,741,640 | April 15, 2020 | March 31, 2027 | NIXON, SARA JO | reporter.nih.gov |
| Center for Mesoscale Mapping | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,740,828 | August 1, 2020 | May 31, 2030 | ROSEN, BRUCE R | reporter.nih.gov |
| 12/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U PITTSBURGH | NIH | National Institute on Drug Abuse | 2021 to 2025 | $6,727,386 | September 30, 2015 | March 31, 2027 | CLARK, DUNCAN B. | reporter.nih.gov |
| Implementing and Personalizing Best-In-Class Opioid-sparing Pain Management for Major Inpatient Surgeries in Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $6,720,269 | September 5, 2024 | August 31, 2029 | SADHASIVAM, SENTHILKUMAR | reporter.nih.gov |
| An Intranasal GDNF Gene Therapy for Opioid Relapse Reduction | NIH | National Institute on Drug Abuse | 2021 | $6,693,512 | September 15, 2021 | August 31, 2025 | WASZCZAK, BARBARA LEE | reporter.nih.gov |
| Early Life Air Pollution Exposures as a Risk Factor for Neurodevelopmental Disorders | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $6,692,816 | August 1, 2021 | July 31, 2029 | CORY-SLECHTA, DEBORAH A | reporter.nih.gov |
| PDE7 Inhibitor for the Treatment of Cocaine Use Disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,689,019 | April 15, 2023 | March 31, 2027 | GAITANARIS, GEORGE | reporter.nih.gov |
| Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD) | NIH | National Institute on Drug Abuse | 2023 to 2024 | $6,654,182 | August 15, 2023 | July 31, 2025 | GRIECO, JOSEPH | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston, MA | 681 | $1.04 billion | 0 | $0 |
| Yale University | New Haven, CT | 561 | $951.4 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 640 | $939.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 550 | $932 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 513 | $904.4 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 631 | $904.2 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 549 | $894.4 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 468 | $754.1 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 460 | $733.6 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 472 | $717.3 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 495 | $685 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 284 | $672.5 million | 0 | $0 |
| Stanford University | Stanford, CA | 436 | $564.1 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 447 | $557.5 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 287 | $545.7 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 347 | $506.1 million | 0 | $0 |
| Emory University | Atlanta, GA | 384 | $490.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 248 | $476.9 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 403 | $449.5 million | 0 | $0 |
| University of Washington | Seattle, WA | 334 | $446.9 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 329 | $436.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 247 | $430.9 million | 0 | $0 |
| Duke University | Durham, NC | 315 | $419.1 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 197 | $417.4 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 142 | $374.5 million | 0 | $0 |
| University of California at Davis | Davis, CA | 242 | $359.2 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 260 | $350.5 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 220 | $336.5 million | 0 | $0 |
| University of Florida | Gainesville, FL | 282 | $333.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 183 | $310.2 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 177 | $297.7 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 161 | $296.9 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 217 | $285 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 242 | $276.6 million | 0 | $0 |
| Brown University | Providence, RI | 158 | $265.5 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 245 | $259.3 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 166 | $253.3 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 200 | $251.2 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 180 | $250.9 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 206 | $242.3 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 168 | $241.8 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 217 | $240.9 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 194 | $227.8 million | 0 | $0 |
| Ohio State University | Columbus, OH | 181 | $213.9 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 158 | $208 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 114 | $195.5 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 79 | $190.5 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 111 | $186.5 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 145 | $182 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 122 | $181.5 million | 0 | $0 |
| New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC | New York, NY | 146 | $174.6 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 97 | $173.7 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 145 | $172.4 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 143 | $171.5 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 122 | $168.6 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 106 | $166.3 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 151 | $166 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 147 | $163.2 million | 0 | $0 |
| University of Rochester | Rochester, NY | 144 | $155.9 million | 0 | $0 |
| University of Chicago | Chicago, IL | 91 | $155.5 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 163 | $154.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 129 | $154.2 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 104 | $149.6 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 103 | $143.7 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 89 | $143.3 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 53 | $142.2 million | 0 | $0 |
| University of South Florida | Tampa, FL | 87 | $141.1 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 197 | $138.9 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 31 | $135.1 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 89 | $130.8 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 144 | $130.1 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 85 | $127.6 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 123 | $126.6 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 63 | $124.9 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 103 | $119.9 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 93 | $119.4 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 61 | $104.1 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 78 | $103.8 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 62 | $100.5 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 97 | $99.7 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 48 | $97.7 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 81 | $96.3 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 52 | $96 million | 0 | $0 |
| Banner Health | Phoenix, AZ | 10 | $91.7 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 38 | $91.6 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 110 | $91.2 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 70 | $90.7 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 73 | $90 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 73 | $89.3 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 72 | $89.3 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 82 | $88.5 million | 0 | $0 |
| Cognition Therapeutics, Inc. | Pittsburgh, PA | 5 | $86.6 million | 0 | $0 |
| New York University | New York, NY | 76 | $86 million | 0 | $0 |
| Drexel University | Philadelphia, PA | 83 | $85.6 million | 0 | $0 |
| Trustees of Boston University | Boston, MA | 88 | $85.3 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 51 | $84.8 million | 0 | $0 |
| ST. Joseph's Hospital and Medical Center | Phoenix, AZ | 33 | $82.6 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 62 | $81.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 49 | $81.2 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 51 | $81 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 11,701 | $7,890,007,355 | 0 | $0 |
| 2024 | 12,759 | $7,753,032,649 | 0 | $0 |
| 2023 | 12,627 | $7,693,723,741 | 0 | $0 |
| 2022 | 12,537 | $7,370,584,106 | 0 | $0 |
| 2021 | 11,867 | $6,875,329,364 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.